December 6th, 2022 | 🕒
iSpeech.org First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening. Acquisition strengthens Molecular Devices' position as
December 6th, 2022 | 🕒
https://www.ispeech.org/text.to.speech First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening We’re excited to bring our domain
September 6th, 2022 | 🕒
https://www.ispeech.org/text.to.speech Cell cultured seafood produced with the same nutrients and texture has been developed through patented organoid technology. Previously used
February 22nd, 2022 | 🕒
iSpeech This article includes research findings that are yet to be peer-reviewed. Results are therefore regarded as preliminary and should
August 18th, 2021 | 🕒
TTS VANCOUVER, British Columbia, August 18, 2021--(BUSINESS WIRE)--STEMCELL Technologies and Hubrecht Organoid Technology (HUB) have announced that they have signed
Gloss